Tag: Janssen Biotech

Biocon Biologics secures license agreement for biosimilar launch in US

businessnewstoday- February 29, 2024

In a landmark announcement, Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, revealed its settlement and license ... Read More

Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets

businessnewstoday- October 13, 2023

In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food and Drug Administration (U.S. FDA) to introduce ... Read More

EMA accepts MAA for Dong-A ST’s Stelara biosimilar, DMB-3115

businessnewstoday- July 17, 2023

Dong-A ST, the South Korean pharmaceutical company, has received confirmation from the European Medicine Agency (EMA) of the acceptance of their Marketing Authorization Application (MAA) ... Read More

FDA authorizes emergency use of Janssen COVID-19 Vaccine

pharmanewsdaily- February 28, 2021

The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine - Ad26.COV2.S manufactured by Johnson & ... Read More

Alligator Bioscience gets FDA approval for IND application of mitazalimab

pharmanewsdaily- December 6, 2020

Alligator Bioscience said that the investigational new drug application for its CD40 targeting antibody mitazalimab has been approved by the US Food and Drug Administration ... Read More

Janssen to acquire skin disease drug candidate bermekimab from XBiotech

pharmanewsdaily- December 8, 2019

Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to acquire all rights to bermekimab, an investigational ... Read More